Skip to main content

Advertisement

SpringerLink
Log in

ASO Author Reflections: Medullary Thyroid Cancer—Establishing Treatment Paradigms in a Rapidly Evolving Therapeutic Landscape

  • ASO Author Reflections
  • Published:
Annals of Surgical Oncology Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

References

  1. Kesby NL, Papachristos AJ, Gild M, et al. Outcomes of advanced MTC in the era of targeted therapy. Ann Surg Oncol. 2021. https://doi.org/10.1245/s10434-021-10980-5.

  2. Oba T, Chino T, Soma A, et al. Comparative efficacy and safety of tyrosine kinase inhibitors for thyroid cancer: a systematic review and meta-analysis. Endocrine J. 2020:EJ20–0171.

  3. Wirth LJ, Sherman E, Robinson B, et al. Efficacy of selpercatinib in RET-altered thyroid cancers. N Engl J Med. 2020;383:825–35.

    Article  CAS  Google Scholar 

  4. Zhuang SM, Xie LE, Pang F, et al. Role of primary tumor resection in patients with metastatic medullary thyroid cancer who have unresectable distant metastases. Head Neck. 2021;43(11):3386–92.

    Article  Google Scholar 

  5. Jozaghi Y, Zafereo M, Williams MD, et al. Neoadjuvant selpercatinib for advanced medullary thyroid cancer. Head Neck. 2021;43:E7-12.

    Article  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Royal North Shore Hospital, Endocrine Surgical Unit, Northern Sydney Local Health District, St. Leonards, NSW, Australia

    Alexander J. Papachristos MBBS, MSurgEd, Anthony R. Glover MBBS, PhD & Stan B. Sidhu MBBS, PhD

  2. Hormones and Cancer Group, Kolling Institute of Medical Research, Royal North Shore Hospital, University of Sydney, Sydney, NSW, Australia

    Alexander J. Papachristos MBBS, MSurgEd & Stan B. Sidhu MBBS, PhD

  3. Faculty of Medicine and Health, Northern Clinical School, Sydney Medical School, University of Sydney, Sydney, NSW, Australia

    Alexander J. Papachristos MBBS, MSurgEd, Anthony R. Glover MBBS, PhD & Stan B. Sidhu MBBS, PhD

  4. Faculty of Medicine, Garvan Institute of Medical Research, Endocrine Cancer Program, The Kinghorn Cancer Centre and St. Vincent’s Clinical School, University of New South Wales, Sydney, NSW, Australia

    Anthony R. Glover MBBS, PhD

Authors
  1. Alexander J. Papachristos MBBS, MSurgEd
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Anthony R. Glover MBBS, PhD
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Stan B. Sidhu MBBS, PhD
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Alexander J. Papachristos MBBS, MSurgEd.

Ethics declarations

Disclosure

There are no conflicts of interest.

Additional information

Publisher's Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Papachristos, A.J., Glover, A.R. & Sidhu, S.B. ASO Author Reflections: Medullary Thyroid Cancer—Establishing Treatment Paradigms in a Rapidly Evolving Therapeutic Landscape. Ann Surg Oncol 29, 72–73 (2022). https://doi.org/10.1245/s10434-021-10989-w

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1245/s10434-021-10989-w

Search

Navigation